A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

H5N1 vaccines have been previously licensed, and millions are in the national stockpile. But even with the news of the ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of ...

San Francisco confirmed that a child in the city became the first case of H5N1. A panel of biotech leaders discussed what ...

“Although individual vaccines have been developed and approved for use in humans against SARS-CoV-2 and influenza viruses, ...

As more cases of bird flu emerge across the country, public health leaders in New York City are watching warily -- and making ...

Unlike the coronavirus, which caused havoc with its ... The Department of Agriculture was slow to begin testing H5N1 vaccines for cows, leaving interested companies in limbo.

Respiratory illness activity remains high across the country, according to the latest data from the Centers for Disease ...

A pandemic is not inevitable, scientists say. But the outbreak has passed worrisome milestones in recent weeks, including ...

To learn more about the recent bird flu outbreaks, we spoke with Asha Shah, MD, director of infectious diseases and ...